eiconol

01/01/1997 - "A placebo-controlled study was made of the efficacy of diet additive of omega-3 polyunsaturated fatty acids (diet oil eiconol) in 27 patients with bronchial asthma (BA). "
01/01/1997 - "Placebo-controlled study of changes in the course of atopic bronchial asthma (ABA) induced by supplement of the diet with polyunsaturated fatty acids of omega-3 class in 13 patients compared to placebo-treated subjects allowed the conclusion on significant attenuation of late allergic response in patients who had taken eiconol for two weeks. "

01/01/1993 - "[Euconol in the treatment of patients with ischemic heart disease]."
01/01/1993 - "The clinical efficacy of the foodstuff euconol was studied in 72 patients with coronary heart diseases, stable angina of effort, postinfarct cardiosclerosis, or silent myocardial ischemia. "
01/01/1996 - "The effectivity of diet AI, containing 20 g of fish oil eiconol, for patients suffering with ischemic heart disease, family hyperlipidemia and hypertension were checked. "
01/01/1994 - "The hypolipidemic, antiatherogenic and thrombolytic effects and decrease of prostaglandin F2 alpha (PG) excretion were observed in 55 patients suffering from Ischemic heart disease, hyperlipidemia and hypertension fed the antiatherosclerotic diet containing 20 g of eiconol during 55 days. "
09/01/1994 - "Patients with ischemic heart disease and with hyperlipidemia of the IIa, IIb and IV types as well as not exhibiting any pronounced alterations in cholesterol metabolism were treated with various amounts of omega-3 polyunsaturated fatty acids (PUFA) introduced into the basic antiatherosclerotic diet: 1 group--content of the essential factor 0.2 g/day, 2 group--increased content of natural products with PUFA up to 1 g/day, 3 group--increased PUFA content due to the drug "euconol" 5 g/day. "

01/01/1994 - "It is suggested that eiconol addition to antiatherosclerotic diet causes no LPO induction and is pathognomonic for HLPE, hypertension and IHD patients."
01/01/1996 - "The effectivity of diet AI, containing 20 g of fish oil eiconol, for patients suffering with ischemic heart disease, family hyperlipidemia and hypertension were checked. "
01/01/1994 - "The hypolipidemic, antiatherogenic and thrombolytic effects and decrease of prostaglandin F2 alpha (PG) excretion were observed in 55 patients suffering from Ischemic heart disease, hyperlipidemia and hypertension fed the antiatherosclerotic diet containing 20 g of eiconol during 55 days. "
01/01/1995 - "Change in lipid peroxidation processes (POL) have been studied in 32 patient with II degree hypertension disease after treatment by diet containing 20 g fish oil (eiconol) and 12.5 or 125 mg of vitamin E. "

01/01/1996 - "[The effects of eiconol in elderly patients with non-insulin-dependent diabetes mellitus]."
01/01/2000 - "[Effects of diet therapy including eiconol on clinical and metabolic parameters in patients with type 2 diabetes mellitus]."
01/01/2000 - "It was investigated the influence of a diet supplemented with PUFA omega-3 ("Eiconol") on dynamic of basal and postprandial glycemia, blood pressure, lipid levels, parameters of lipid peroxidation in 60 patients with non-insulin-dependent diabetes mellitus. "
01/01/1996 - "[Experience in the use of eiconol (a complex of unsaturated fatty acids) in non-insulin-dependent diabetes mellitus]."
01/01/2001 - "[Comparative study of effects of diet therapy including eiconol or linseed oil on several parameters of lipid metabolism in patients with type 2 diabetes mellitus]."

01/01/1996 - "The effectivity of diet AI, containing 20 g of fish oil eiconol, for patients suffering with ischemic heart disease, family hyperlipidemia and hypertension were checked. "
01/01/1994 - "The hypolipidemic, antiatherogenic and thrombolytic effects and decrease of prostaglandin F2 alpha (PG) excretion were observed in 55 patients suffering from Ischemic heart disease, hyperlipidemia and hypertension fed the antiatherosclerotic diet containing 20 g of eiconol during 55 days. "
09/01/1994 - "Patients with ischemic heart disease and with hyperlipidemia of the IIa, IIb and IV types as well as not exhibiting any pronounced alterations in cholesterol metabolism were treated with various amounts of omega-3 polyunsaturated fatty acids (PUFA) introduced into the basic antiatherosclerotic diet: 1 group--content of the essential factor 0.2 g/day, 2 group--increased content of natural products with PUFA up to 1 g/day, 3 group--increased PUFA content due to the drug "euconol" 5 g/day. "